Since the initial finding by Al-Hajj et al. reporting that a small population of CD44+CD24−/low breast cancer cells had the ability to form new tumors with as few as a couple hundred cells whereas tens of thousands of cells with alternate phenotypes failed to produce tumors (46), there has been active discussion in the hypothesis of stem cell origin of breast cancer. This evidence concerns the gene CD44 and breast carcinoma.